These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12972115)

  • 1. Relation between QT dispersion and myocardial viability in ischemic cardiomyopathy.
    Schinkel AF; Bountioukos M; Poldermans D; Elhendy A; Valkema R; Vourvouri EC; Biagini E; Rizzello V; Kertai MD; Krenning B; Krenning EP; Roelandt JR; Bax JJ
    Am J Cardiol; 2003 Sep; 92(6):712-5. PubMed ID: 12972115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of positron emission tomography with the resting electrocardiogram for assessing viable myocardium in chronic ischemic cardiomyopathy involving the anterior left ventricular wall.
    Desideri A; Zanco P; Bertella M; Bigi R; Cortigiani L; Bax J; Suzzi G; Celegon L
    Am J Cardiol; 2002 Oct; 90(8):878-82. PubMed ID: 12372579
    [No Abstract]   [Full Text] [Related]  

  • 3. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction.
    Uebleis C; Hellweger S; Laubender RP; Becker A; Sohn HY; Lehner S; Haug A; Bartenstein P; Cumming P; Van Kriekinge SD; Slomka PJ; Hacker M
    Int J Cardiovasc Imaging; 2013 Oct; 29(7):1645-53. PubMed ID: 23744128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment.
    Santana CA; Faber TL; Soler-Peter M; Sanyal R; Esteves FP; Ornelas M; Folks RD; Verdes L; Santana LF; Candell-Riera J; Garcia EV
    Nucl Med Commun; 2008 Nov; 29(11):970-81. PubMed ID: 18836375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-photon emission computed tomography for assessment of myocardial viability.
    Schinkel AF; Valkema R; Geleijnse ML; Sijbrands EJ; Poldermans D
    EuroIntervention; 2010 May; 6 Suppl G():G115-22. PubMed ID: 20542817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction.
    Schinkel AF; Bax JJ; Sozzi FB; Boersma E; Valkema R; Elhendy A; Roelandt JR; Poldermans D
    Heart; 2002 Aug; 88(2):125-30. PubMed ID: 12117829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular mechanical dyssynchrony analzyed by Tc-99m sestamibi SPECT and F-18 FDG PET in patients with ischemic cardiomyopathy and the prognostic value.
    Tian Y; Zhao M; Li W; Zhu Z; Mi H; Li X; Zhang X
    Int J Cardiovasc Imaging; 2020 Oct; 36(10):2063-2071. PubMed ID: 32495064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rest-redistribution 201-Thallium single photon emission computed tomography predicts myocardial infarction and cardiac death in patients with ischemic left ventricular dysfunction.
    Perrone-Filardi P; Pace L; Dellegrottaglie S; Corrado L; Prastaro M; Cafiero M; Caiazzo G; Marzano A; Cesarano P; Gargiulo P; Paolillo S; Maglione A; Petretta A; Chiariello M
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):122-8. PubMed ID: 19377379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Myocardial Viability in Ischemic Cardiomyopathy With Reduced Left Ventricular Function Undergoing Coronary Artery Bypass Grafting.
    Arjomandi Rad A; Tserioti E; Magouliotis DE; Vardanyan R; Samiotis IV; Skoularigis J; Ariff B; Xanthopoulos A; Triposkiadis F; Casula R; Athanasiou T
    Clin Cardiol; 2024 Jul; 47(7):e24307. PubMed ID: 38953367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease.
    Mc Ardle B; Shukla T; Nichol G; deKemp RA; Bernick J; Guo A; Lim SP; Davies RA; Haddad H; Duchesne L; Hendry P; Masters R; Ross H; Freeman M; Gulenchyn K; Racine N; Humen D; Benard F; Ruddy TD; Chow BJ; Mielniczuk L; DaSilva JN; Garrard L; Wells GA; Beanlands RS;
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27609816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographically concealed variation in left ventricular capture: a case with implications for resynchronization therapy in ischemic cardiomyopathy.
    Grimley SR; Suffoletto MS; Gorcsan J; Schwartzman D
    Heart Rhythm; 2006 Jun; 3(6):739-42. PubMed ID: 16731481
    [No Abstract]   [Full Text] [Related]  

  • 13. Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons.
    Ogawa M; Doi K; Fukumoto A; Yaku H
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):673-5. PubMed ID: 17670732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcomes of patients with severe left ventricular dysfunction undergoing cardiac MRI viability assessment prior to revascularization.
    Doukas D; Porcaro K; Marot J; Burke L; Joyce C; Weaver F; Nguyen J; Cao JJ; Mathew V; Heroux A; Syed MA
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):675-684. PubMed ID: 33034865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial technetium-99m-tetrofosmin single-photon emission computed tomography compared with 18F-fluorodeoxyglucose imaging to assess myocardial viability.
    Schinkel AF; Bax JJ; Biagini E; Elhendy A; van Domburg RT; Valkema R; Rizzello V; Schouten O; Simoons M; Poldermans D
    Am J Cardiol; 2005 May; 95(10):1223-5. PubMed ID: 15877995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
    Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R
    Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT dispersion is determined by the extent of viable myocardium in patients with chronic Q-wave myocardial infarction.
    Schneider CA; Voth E; Baer FM; Horst M; Wagner R; Sechtem U
    Circulation; 1997 Dec; 96(11):3913-20. PubMed ID: 9403615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromechanical mapping for detecting myocardial viability and ischemia in patients with severe ischemic cardiomyopathy.
    Samady H; Liu YH; Choi CJ; Ragosta M; Pfau SE; Cleman MW; Powers ER; Kramer CM; Wackers FJ; Beller GA; Watson DD
    Am J Cardiol; 2003 Apr; 91(7):807-11. PubMed ID: 12667565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial contrast echocardiography in chronic ischemic and nonischemic cardiomyopathies.
    Monakier D; Woo A; Vannan MA; Rakowski H
    Cardiol Clin; 2004 May; 22(2):269-82. PubMed ID: 15158939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.
    Mahmarian JJ; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Hendel RC; Moye LA; Olmsted AW
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):959-68. PubMed ID: 19679284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.